Exosome-Mediated Drug Delivery for Cell-Free Therapy of Osteoarthritis

Author(s): Li Duan*, Xiao Xu, Limei Xu, Hongfei Chen, Xingfu Li, Murad Alahdal, Yin Xiao, Yujie Liang*, Jiang Xia*

Journal Name: Current Medicinal Chemistry

Volume 28 , Issue 31 , 2021

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Osteoarthritis (OA) is a degenerative disease of cartilage and bones, which results in severely compromised quality of life in the aged population. However, currently, no ideal treatment strategies have been developed to prevent OA progression. Cell therapies, such as chondrocyte and MSC transplantation, have been extensively tested and evaluated in clinical trials. Yet, to day, the clinical efficacy of articular injection of stem cells in OA has not been convincingly demonstrated. Recent studies have indicated that exosomes, one type of Extracellular Vesicles (EVs) play an important regulatory role in the pathogenesis of OA, suggesting the prospective therapeutic application of exosomes in OA treatment. In this review, we systematically summarized the paracrine effects of exosomes derived from MSCs and chondrocytes on cartilage regeneration, the use of exosomes as a delivery vehicle for OA treatment, the effectiveness of such treatments in OA animal models, and the future perspective of exosome-mediated drug delivery as a cell- free therapy of OA.

Keywords: Exosome, targeted drug delivery, mesenchymal stem cells, chondrocytes, osteoarthritis, extracellular vesicles.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 18 November, 2020
Page: [6458 - 6483]
Pages: 26
DOI: 10.2174/0929867327666201118161232
Price: $65

Article Metrics

PDF: 298